Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2361 (LINC02361) is a gene that encodes a long non-coding RNA (lncRNA) molecule, specifically classified as a long intergenic non-protein coding RNA (lincRNA)[1][5]. LincRNAs are RNA transcripts longer than 200 nucleotides, do not code for proteins, and are located in genomic regions that do not overlap protein-coding genes[7][9]. While many lincRNAs have regulatory roles in epigenetic and transcriptional control, the specific biological functions, disease associations, and therapeutic relevance of LINC02361 remain uncharacterized in current published literature[1][5][7][9]. There are no known drugs, biomarkers, or safety concerns directly related to this lincRNA. Its main biological relevance—if any—likely involves fine-tuning of gene expression or chromatin state, as is typical for lincRNAs[7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2361 (LINC02361).